openPR Logo
Press release

New Breast Cancer Knowledge Centre launches on epgonline.org, the website for healthcare professionals

09-29-2016 03:58 PM CET | Health & Medicine

Press release from: EPG Health Media

A new clinical resource has launched on epgonline.org this week. The Breast Cancer Knowledge Centre is intended for oncologists and other healthcare professionals involved in the treatment and care of patients with this condition.

Breast cancer is the second most common cancer worldwide. It has the highest 5-year global prevalence of any cancer type, which is estimated to have increased by 21% since 2008 to 6.3 million women in 20121. It is the fifth highest cause of cancer-related death worldwide2 and the leading cause of cancer-related death in women, accounting for 15% of the total3. The global economic cost of breast cancer was estimated at $88 billion in 2008, with only lung cancer and colorectal cancer having a greater economic burden4.

Healthcare professionals can register free of charge on epgonline.org to access this resource: https://www.epgonline.org/breast-cancer-knowledge-centre/en/index.cfm. Information within the Breast Cancer Knowledge Centre is split into key sections and subsections for easy accessibility. The ‘Disease Awareness’ section compiles fully referenced facts and statistics on breast cancer, including epidemiology, pathophysiology, signs & symptoms, diagnosis & staging and prognosis. A summary of the four intrinsic subtypes, key signalling pathways and the evidence to support each classification is available in the ‘Molecular Subtypes’ section. The ‘Treatment’ section comprises current treatment guidelines and explores the different therapies available for each subtype of breast cancer. The ‘HR+ Aggressive’ section contains detailed information on hormone receptor positive aggressive breast cancer, including metastatic subtypes, current best practice guidelines, treatment therapy options and an overview of the recent ASCO expert panel evaluation of randomised phase II and III clinical trials. Lastly, a resources section pulls together useful external links to workshops and patient information tools, an upcoming oncology events calendar and links to official European medical association and society websites.

Dr Toby Galbraith, Director of Content Strategy for epgonline.org, said: “Breast cancer is a disease touching the lives of many people, and there is a very active field of clinical research trying to tackle it. We hope that healthcare professionals will find our new resource useful in bringing together the latest research and clinical thinking on breast cancer, illustrated and summarised in an accessible manner.” The Breast Cancer Knowledge Centre has been developed by EPG Health Media for epgonline.org, in collaboration with F. Hoffmann-La Roche Ltd, who reviewed the content for clinical accuracy.

ENDS

Notes to Editors:

EPG Health Media is a digital communications company and publisher of epgonline.org, which provides healthcare professionals worldwide with free access to a wealth of clinical content, carefully developed and curated from trustworthy sources and conveniently organised by disease, medical specialty and information type. Content includes localised prescription drug information, disease-focused 'Learning Zones', treatment guidelines, drug and industry news, clinical trial information and journal article abstracts.
Roche is a global, research-focused healthcare company with Group Headquarters in Basel, Switzerland. They are a leading provider of pharmaceutical treatments for cancer and viral diseases and a major supplier of medicines for the treatment of transplantation, virology, bone and rheumatology and renal anaemia. In total, the company employs over 90,000 people across more than 100 countries.

References:

Bray F, Ren J-S, Masuyer E, Ferley J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133–1145.
World Health Organization (WHO)/International Agency for Research on Cancer (IARC). GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx?cancer=breast (last accessed January 2016).
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
American Cancer Society (ACS). Global burden of cancer. 2008. Available at: http://cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf (last accessed January 2016).

EPG Health Media is a digital communications company and publisher of epgonline.org, which provides healthcare professionals worldwide with free access to a wealth of clinical content, carefully developed and curated from trustworthy sources and conveniently organised by disease, medical specialty and information type. Content includes localised prescription drug information, disease-focused 'Learning Zones', treatment guidelines, drug and industry news, clinical trial information and journal article abstracts.

Kristie Marchant (Senior Marketing Executive)
EPG Health Media
51-55 The Pantiles
Tunbridge Wells
Kent
TN2 5TE

press@epghealthmedia.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Breast Cancer Knowledge Centre launches on epgonline.org, the website for healthcare professionals here

News-ID: 368234 • Views: 382

More Releases from EPG Health Media

New clinical resource presents the latest evidence of effective procedures for f …
epgonline.org is pleased to announce the latest addition to its range of educational resources for healthcare professionals. The Fluid Management Knowledge Centre is intended as a learning tool to educate healthcare professionals on effective procedures for fluid management in a selection of clinical scenarios. Currently, the choice of intravenous fluids used for the resuscitation of acutely ill patients in clinical practice is determined mainly by clinician preference1. However, emerging evidence
New multi-language Transplantation Knowledge Centre for healthcare professionals …
A new clinical resource has launched on epgonline.org, the website for healthcare professionals. The Transplantation Knowledge Centre is intended as a learning tool to provide online access to information on a variety of topics related to transplantation, including surgical procedures and future developments in the field. Although short term survival of transplantation surgery is excellent (>90%), long term survival rates are poor due to recurrence of disease, development of
New hidradenitis suppurativa (acne inversa) clinical resource launches this week …
epgonline.org, the website for healthcare professionals, has recently announced the addition of a new clinical resource on hidradenitis suppurativa (HS), also known as acne inversa. The Hidradenitis Suppurativa Knowledge Centre presents information in a series of key sections, including disease awareness information and treatment options using both conventional and newer biologic agents. HS is a chronic, recurrent, inflammatory skin disease, which commonly develops post-puberty in skin regions bearing apocrine glands,
Launch of new lysosomal acid lipase deficiency educational resource on epgonline …
epgonline.org, the website for healthcare professionals, has today announced the launch of a new educational resource for lysosomal acid lipase (LAL) deficiency. The LAL Deficiency Knowledge Centre is intended to provide important disease awareness and treatment information to healthcare professionals involved in the treatment and management of this extremely rare and life-limiting disorder. LAL deficiency is an autosomal recessive lysosomal storage disorder resulting in marked lysosomal accumulation of cholesteryl

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and